Cesano Alessandra
- SEC CIK
- 0001827015
In the past year, 1 open-market sale filing worth $567.0K and no purchases.
Current role at each company
- PBYI Puma Biotechnology, Inc.Directoras of Sep 16, 2026
- ZYME Zymeworks Inc.Directoras of Jan 12, 2026
- SMMT Summit Therapeutics Inc.Directoras of Jan 6, 2026
- EPIX ESSA Pharma Inc.Chief Medical Officeras of Mar 28, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $567.0K
- 1 filing
- Net
- −$567.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Cesano Alessandra as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PBYI Puma Biotechnology, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2025 (view filing) | Jun 13 | 4 days | Cesano AlessandraDirector | SSale | −12.2K | $3.40 | −$41.3K | −15.0%68.8K after | 10b5-1 |
| Jul 22, 2025 (view filing) | Jul 18 | 4 days | Cesano AlessandraDirector | SSale | −27.0K | $3.37 | −$91.0K | −39.2%41.9K after | 10b5-1 |
| Sep 16, 2026 (view filing)9:06 PM ET | Sep 14 | 2 days | Cesano AlessandraDirector | SSale | −62.1K | $9.12 | −$567.0K | −52.3%56.7K after | 10b5-1 |